Trial Profile
Prevention of Systemic Toxicity Induced by Levobupivacaine and Ropivacaine by Intralipid
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2013
Price :
$35
*
At a glance
- Drugs Levobupivacaine (Primary) ; Ropivacaine (Primary) ; Soya oil emulsion
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2012 New trial record